Alignment Healthcare (ALHC) Stock Price, News & Analysis

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Alignment Healthcare in the last twelve months. There are currently 1 sell rating, 4 hold ratings, 3 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" ALHC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ALHC, but not buy additional shares or sell existing shares.
View ALHC analyst ratings or view top-rated stocks.

9 Wall Street research analysts have issued 1 year price targets for Alignment Healthcare's stock. Their ALHC share price targets range from $4.50 to $12.00. On average, they predict the company's stock price to reach $9.38 in the next twelve months. This suggests a possible upside of 81.7% from the stock's current price.
View analysts price targets for ALHC or view top-rated stocks among Wall Street analysts.

Alignment Healthcare's stock was trading at $8.61 on January 1st, 2024. Since then, ALHC stock has decreased by 40.1% and is now trading at $5.16.
View the best growth stocks for 2024 here.

Alignment Healthcare saw a drop in short interest during the month of March. As of March 31st, there was short interest totaling 3,940,000 shares, a drop of 17.6% from the March 15th total of 4,780,000 shares. Based on an average daily trading volume, of 891,100 shares, the short-interest ratio is presently 4.4 days. Approximately 4.4% of the company's stock are sold short.
View Alignment Healthcare's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024.
View our ALHC earnings forecast.

Alignment Healthcare will be holding an earnings conference call on Thursday, May 2nd at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link.

Alignment Healthcare, Inc. (NASDAQ:ALHC) announced its earnings results on Tuesday, February, 27th. The company reported ($0.25) earnings per share for the quarter, missing the consensus estimate of ($0.22) by $0.03. The firm had revenue of $465.39 million for the quarter, compared to analyst estimates of $444.56 million. Alignment Healthcare had a negative net margin of 8.12% and a negative trailing twelve-month return on equity of 75.64%. The business's revenue was up 28.6% on a year-over-year basis. During the same quarter in the prior year, the business posted ($0.31) EPS.

Alignment Healthcare issued an update on its first quarter 2024 earnings guidance on Tuesday, February, 27th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $590.0 million-$600.0 million, compared to the consensus revenue estimate of $550.8 million.

Alignment Healthcare (ALHC) raised $490 million in an initial public offering (IPO) on Friday, March 26th 2021. The company issued 27,200,000 shares at $17.00-$19.00 per share. Goldman Sachs, Morgan Stanley, J.P. Morgan, BofA Securities and William Blair served as the underwriters for the IPO and UBS Investment Bank, Piper Sandler and Raymond James were co-managers.

Alignment Healthcare's stock is owned by a number of retail and institutional investors. Top institutional investors include Allspring Global Investments Holdings LLC (0.02%). Insiders that own company stock include Atlantic (Aln Hlth) L General, Christopher J Joyce, Dawn Christine Maroney, Dinesh M Kumar, Donald Steven Furman, Jeffrey H Margolis, John E Kao, Joseph S Konowiecki, Richard A Cross, Robert L Scavo, Robert Thomas Freeman and Warburg Pincus Partners Gp Llc.
View institutional ownership trends.

Shares of ALHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.